Linked Data API

Show Search Form

Search Results

436264
star this property registered interest false more like this
star this property date less than 2015-12-08more like thismore than 2015-12-08
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading NHS: Innovation more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, whether he plan to respond to the Accelerated Access Review: Interim Report, published in October 2015; and if he will make a statement. more like this
star this property tabling member constituency Crawley more like this
star this property tabling member printed
Henry Smith remove filter
star this property uin 19241 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2015-12-15more like thismore than 2015-12-15
star this property answer text <br /><p>The Interim Report of Sir Hugh Taylor’s Accelerated Access Review (AAR) is a deliberately high level document that indicates direction of travel; as such, government will be responding to the AAR’s conclusions when its final recommendations are published early in the spring of 2016.</p> more like this
star this property answering member constituency Mid Norfolk more like this
star this property answering member printed George Freeman more like this
star this property question first answered
less than 2015-12-15T16:30:10.483Zmore like thismore than 2015-12-15T16:30:10.483Z
star this property answering member
4020
star this property label Biography information for George Freeman remove filter
star this property tabling member
3960
unstar this property label Biography information for Henry Smith more like this
155948
star this property registered interest false more like this
star this property date less than 2014-11-17more like thismore than 2014-11-17
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading Prescription Drugs more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, what steps his Department is taking to encourage flexibility in the licensing process for potential new treatments for rare conditions. more like this
star this property tabling member constituency Crawley more like this
star this property tabling member printed
Henry Smith remove filter
star this property uin 214491 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2014-11-24more like thismore than 2014-11-24
star this property answer text <p>Most new medicines for rare conditions are licensed by the European Commission.</p><p> </p><p>The European Union offers a range of incentives to encourage the development of these medicines in order to address unmet clinical need. These incentives include a period of 10 years market exclusivity, the provision of Protocol Assistance (scientific advice specifically tailored for orphan medicinal products) and fee reductions and waivers for regulatory procedures.</p><p> </p><p> </p><p> </p><p>Through the Medicines and Healthcare products Regulatory Agency (MHRA), the United Kingdom takes an active role in the decision making process at the European Medicines Agency’s Committee on Orphan Medicinal Products, ensuring applications for Orphan Drug designation of potential drug candidates for rare diseases are appropriately recognised, encouraging companies to develop their products further and recommending use of existing flexibilities such as conditional authorisation, authorisation under exceptional circumstances and accelerated assessment. The UK is actively involved in the European Medicines Agency’s adaptive licensing pilot that is exploring further use of these flexibilities. The MHRA has an Innovation Office that can offer advice and assistance to developers of drugs for rare diseases, including on the use of flexibilities.</p><p> </p><p><strong> </strong></p><p> </p><p>In addition, in the UK, the Early Access to Medicines Scheme aims to give patients with life threatening or seriously debilitating conditions access to medicines that do not yet have a marketing authorisation when there is a clear unmet medical need.</p><p> </p><p> </p><p> </p><p>We are also commissioning an external review of the pathways for the development, assessment, and adoption of innovative medicines and medical technology. This review will consider how to speed up access for NHS patients to cost-effective new diagnostics, medicines and devices.</p><p> </p><p><strong> </strong></p><p> </p><p><strong> </strong></p><p> </p>
star this property answering member constituency Mid Norfolk more like this
star this property answering member printed George Freeman more like this
star this property question first answered
less than 2014-11-24T17:23:13.99Zmore like thismore than 2014-11-24T17:23:13.99Z
star this property answering member
4020
star this property label Biography information for George Freeman remove filter
star this property tabling member
3960
unstar this property label Biography information for Henry Smith more like this
436265
star this property registered interest false more like this
star this property date less than 2015-12-08more like thismore than 2015-12-08
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading Leukaemia: Drugs more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, if he will ensure that the new Cancer Drugs Fund will increase patient access to medicines for acute myeloid leukaemia. more like this
star this property tabling member constituency Crawley more like this
star this property tabling member printed
Henry Smith remove filter
star this property uin 19240 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2015-12-15more like thismore than 2015-12-15
star this property answer text <p>NHS England and the National Institute for Health and Care Excellence are currently consulting jointly on draft proposals on the future direction of the Cancer Drugs Fund.</p><br /><p>The consultation was published on 19 November 2015 and is open until 11 February 2016. It states that it is looking to put in place a solution that ensures patients have routine access to a greater range of cancer drugs, including earlier access to innovative drugs, while ensuring that cost-effectiveness is maintained. Further information is available at:</p><p>www.engage.england.nhs.uk/consultation/cdf-consultation</p> more like this
star this property answering member constituency Mid Norfolk more like this
star this property answering member printed George Freeman more like this
star this property question first answered
less than 2015-12-15T16:22:51.767Zmore like thismore than 2015-12-15T16:22:51.767Z
star this property answering member
4020
star this property label Biography information for George Freeman remove filter
star this property tabling member
3960
unstar this property label Biography information for Henry Smith more like this
434008
star this property registered interest false more like this
star this property date less than 2015-12-03more like thismore than 2015-12-03
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading NHS: Innovation more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, what steps he is taking to ensure the outcome of the consultation on the future of the Cancer Drugs Fund is co-ordinated with and complements the recommendations of the Accelerated Access Review to ensure improved patient access to innovative treatments. more like this
star this property tabling member constituency Crawley more like this
star this property tabling member printed
Henry Smith remove filter
star this property uin 18766 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2015-12-10more like thismore than 2015-12-10
star this property answer text <p>NHS England and the National Institute for Health and Care Excellence are currently consulting on draft proposals on the future direction of the Cancer Drugs Fund (CDF). The consultation is open until 11 February 2016 and further information is available at:</p><br /><p>www.engage.england.nhs.uk/consultation/cdf-consultation</p><br /><p>The Accelerated Access Review independently chaired by Sir Hugh Taylor, is working with key stakeholders on a range of options for accelerating patient access to innovative products, as set out in the interim report. This includes consideration of the impact of managed access schemes such as proposed in the CDF consultation.</p> more like this
star this property answering member constituency Mid Norfolk more like this
star this property answering member printed George Freeman more like this
star this property question first answered
less than 2015-12-10T14:04:50.203Zmore like thismore than 2015-12-10T14:04:50.203Z
star this property answering member
4020
star this property label Biography information for George Freeman remove filter
star this property tabling member
3960
unstar this property label Biography information for Henry Smith more like this
434007
star this property registered interest false more like this
star this property date less than 2015-12-03more like thismore than 2015-12-03
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading Myeloma more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, what steps he is taking to ensure that the treatment of patients with multiple myeloma is not affected by the (a) delisting of treatments from the Cancer Drugs Fund and (b) ongoing consultation on that Fund's future. more like this
star this property tabling member constituency Crawley more like this
star this property tabling member printed
Henry Smith remove filter
star this property uin 18734 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2015-12-10more like thismore than 2015-12-10
star this property answer text <p>NHS England has advised that a draft treatment pathway for patients with multiple myeloma, which takes into account the potential impact of treatments removed from the Cancer Drugs Fund (CDF), is currently being finalised. It is likely to be published early in 2016.</p><br /><p>The Government remains committed to the Fund. NHS England and the National Institute for Health and Care Excellence are currently consulting on draft proposals on the future direction of the CDF. The consultation is open until 11 February 2016 and further information is available at:</p><br /><p>www.engage.england.nhs.uk/consultation/cdf-consultation</p> more like this
star this property answering member constituency Mid Norfolk more like this
star this property answering member printed George Freeman more like this
star this property question first answered
less than 2015-12-10T14:17:08.253Zmore like thismore than 2015-12-10T14:17:08.253Z
star this property answering member
4020
star this property label Biography information for George Freeman remove filter
star this property tabling member
3960
unstar this property label Biography information for Henry Smith more like this
428358
star this property registered interest false more like this
star this property date less than 2015-11-16more like thismore than 2015-11-16
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading Cancer: Drugs more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, what steps he is taking to improve the assessment of medicines for rarer cancers with small patient populations. more like this
star this property tabling member constituency Crawley more like this
star this property tabling member printed
Henry Smith remove filter
star this property uin 16497 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2015-11-23more like thismore than 2015-11-23
star this property answer text <p>NHS England has advised that it intends to jointly consult with the National Institute for Health and Care Excellence on proposals for a new Cancer Drugs Fund operating model. This will include the future arrangements for the evaluation of cancer drugs, including drugs for rarer cancers with small patient populations. Members of the public and any interested parties will have the opportunity to consider and comment on these proposals.</p> more like this
star this property answering member constituency Mid Norfolk more like this
star this property answering member printed George Freeman more like this
star this property grouped question UIN 16188 more like this
star this property question first answered
less than 2015-11-23T10:58:14.527Zmore like thismore than 2015-11-23T10:58:14.527Z
star this property answering member
4020
star this property label Biography information for George Freeman remove filter
star this property tabling member
3960
unstar this property label Biography information for Henry Smith more like this
226307
star this property registered interest false more like this
star this property date less than 2015-03-10more like thismore than 2015-03-10
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading NHS: Research more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, pursuant to the Answer of 24 February 2015 to Question 223768, on which dates since 24 November 2014 he has discussed with NHS England its revised approach to promoting and taking account of research in the new healthcare system; and what the content of those discussions was. more like this
star this property tabling member constituency Crawley more like this
star this property tabling member printed
Henry Smith remove filter
star this property uin 227007 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2015-03-17more like thismore than 2015-03-17
star this property answer text <p>Since 24 November 2014, there have been no discussions between my Rt. Hon. Friend the Secretary of State for Health and NHS England on its revised approach to promoting and taking account of research in the new healthcare system. However, discussions between senior officials in the Department and NHS England are ongoing.</p><p> </p><p> </p><p> </p><p>NHS England will be setting out high level plans through their Business Plan, which is due to be published on 27 March 2015. NHS England does not routinely consult on business plans and, as such, no formal consultation has been planned.</p><p> </p> more like this
star this property answering member constituency Mid Norfolk more like this
star this property answering member printed George Freeman more like this
star this property grouped question UIN 227008 more like this
star this property question first answered
less than 2015-03-17T16:19:17.01Zmore like thismore than 2015-03-17T16:19:17.01Z
star this property answering member
4020
star this property label Biography information for George Freeman remove filter
star this property tabling member
3960
unstar this property label Biography information for Henry Smith more like this
226308
star this property registered interest false more like this
star this property date less than 2015-03-10more like thismore than 2015-03-10
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading NHS: Research more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, pursuant to the Answer of 24 February 2015 to Question 223768, when NHS England plans to publish its revised approach to promoting and taking account of research in the new healthcare system; and what plans NHS England has to hold a formal consultation on that revised approach. more like this
star this property tabling member constituency Crawley more like this
star this property tabling member printed
Henry Smith remove filter
star this property uin 227008 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2015-03-17more like thismore than 2015-03-17
star this property answer text <p>Since 24 November 2014, there have been no discussions between my Rt. Hon. Friend the Secretary of State for Health and NHS England on its revised approach to promoting and taking account of research in the new healthcare system. However, discussions between senior officials in the Department and NHS England are ongoing.</p><p> </p><p> </p><p> </p><p>NHS England will be setting out high level plans through their Business Plan, which is due to be published on 27 March 2015. NHS England does not routinely consult on business plans and, as such, no formal consultation has been planned.</p><p> </p> more like this
star this property answering member constituency Mid Norfolk more like this
star this property answering member printed George Freeman more like this
star this property grouped question UIN 227007 more like this
star this property question first answered
less than 2015-03-17T16:19:16.887Zmore like thismore than 2015-03-17T16:19:16.887Z
star this property answering member
4020
star this property label Biography information for George Freeman remove filter
star this property tabling member
3960
unstar this property label Biography information for Henry Smith more like this
174759
star this property registered interest false more like this
star this property date less than 2015-01-20more like thismore than 2015-01-20
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading Bile Duct Cancer more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, what research his Department has commissioned into cholangiocarcinoma. more like this
star this property tabling member constituency Crawley more like this
star this property tabling member printed
Henry Smith remove filter
star this property uin 221396 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2015-01-27more like thismore than 2015-01-27
star this property answer text <p>The Department has not commissioned any research relating specifically to cholangiocarcinoma. The National Institute for Health Research Imperial Biomedical Research Centre has a £3.6 million gastroenterology and hepatology research theme (2012-17). This includes research on cholangiocarcinoma biomarkers and imaging.</p><p> </p> more like this
star this property answering member constituency Mid Norfolk more like this
star this property answering member printed George Freeman more like this
star this property question first answered
less than 2015-01-27T12:35:01.583Zmore like thismore than 2015-01-27T12:35:01.583Z
star this property answering member
4020
star this property label Biography information for George Freeman remove filter
star this property tabling member
3960
unstar this property label Biography information for Henry Smith more like this
178540
star this property registered interest false more like this
star this property date less than 2015-02-09more like thismore than 2015-02-09
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading NHS: Research more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, when he expects to publish the results of the consultation for the NHS England Research and Development Strategy. more like this
star this property tabling member constituency Crawley more like this
star this property tabling member printed
Henry Smith remove filter
star this property uin 223768 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2015-02-24more like thismore than 2015-02-24
star this property answer text <p>The consultation for the NHS England Research and Development Strategy closed in December 2013. NHS England subsequently decided not to publish the results of the consultation at that time, but instead to use the findings to inform a new piece of work which would be developed with the Department which will describe NHS England’s role in promoting and taking account of research in the new healthcare system.</p><p> </p><p> </p><p> </p><p>NHS England is working with the Department to agree a revised approach.</p><p> </p><p> </p><p> </p><p>Delivery of NHS England’s research objective was discussed at the accountability meeting on 14 October 2014. The minutes of this meeting are available at:</p><p> </p><p> </p><p> </p><p><a href="https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/377477/SofS_Accountability_Meeting_oct_2014.pdf" target="_blank">https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/377477/SofS_Accountability_Meeting_oct_2014.pdf</a></p><p> </p>
star this property answering member constituency Mid Norfolk more like this
star this property answering member printed George Freeman more like this
star this property question first answered
less than 2015-02-24T16:49:23.607Zmore like thismore than 2015-02-24T16:49:23.607Z
star this property answering member
4020
star this property label Biography information for George Freeman remove filter
star this property tabling member
3960
unstar this property label Biography information for Henry Smith more like this